HDFC Pharma and Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
HDFC Pharma and Healthcare Fund - Regular (G)
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹227 Cr | ₹1909 Cr |
Min Investment | ₹5000 | ₹100 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹100 |
Launch Date | 08 Nov 2021 | 04 Oct 2023 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare Index |
Turn Over | % | % |
Expense Ratio | 2.35 | 2.14 |
Manager | Rohan Korde | Dhruv Muchhal |
ISIN Code | INF00XX01BL5 | INF179KC1HL7 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
1 Month | 0.51% | 0.27% |
6 Month | 9.91% | 13.51% |
1 Year | -3.67% | 7.22% |
3 Year | 22.03% | - |
5 Year | - | - |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
6 Month | 1.94% | 5.23% |
1 Year | 3.79% | 15.8% |
3 Year | 19.77% | - |
5 Year | - | - |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
1 Year | 19.5% | 29.56% |
3 Year | 19.53% | - |
5 Year | - | - |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Standard Deviation | 15.57% | - |
Sharp | 0.86% | - |
Beta | 0.95% | - |
Alpha | -2.07% | - |
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Name | Rohan Korde | Dhruv Muchhal |
Total AUM | ₹4626 Cr | ₹520687 Cr |
Funds Managed | 10 | 40 |
ITI Pharma and Healthcare Fund Regular - Growth | HDFC Pharma and Healthcare Fund - Regular (G) |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Others | 4.23 | 8.17 |
Large Cap | 29.73 | 29 |
Mid Cap | 37.1 | 27.19 |
Small Cap | 28.95 | 35.64 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
HDFC Pharma and Healthcare Fund - Regular (G) |
---|---|---|
Others | 2.13 | 1.1 |
Healthcare | 90.65 | 96.46 |
Basic Materials | 3.99 | 2.44 |
Industrials | 1.99 | - |
Financial Services | 1.24 | - |
Top Comparisons
Mahindra Manulife Focused Fund - Regular Plan - Growth
3Y Returns19.42%
Aditya Birla Sun Life Focused Equity Fund -Growth Option
3Y Returns16.13%
Kotak Pioneer Fund- Regular Plan- Growth Option
3Y Returns22.69%
Aditya Birla Sun Life Special Opportunities Fund-Regular Plan-Growth
3Y Returns18.55%
Axis Global Innovation Fund of Fund - Regular Plan - Growth
3Y Returns23.66%
Sundaram Global Brand Theme - Equity Active FOF Regular Growth
3Y Returns20.92%
Nippon India Power & Infra Fund-Growth Plan -Growth Option
3Y Returns28.19%
Invesco India Infrastructure Fund - Growth Option
3Y Returns25.5%